BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22195921)

  • 1. A novel oral colon-targeting drug delivery system based on resistant starch acetate.
    Chen L; Pu H; Li X; Yu L
    J Control Release; 2011 Nov; 152 Suppl 1():e51-2. PubMed ID: 22195921
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of resistant starch film properties on the colon-targeting release of drug from coated pellets.
    Li X; Liu P; Chen L; Yu L
    J Control Release; 2011 Nov; 152 Suppl 1():e5-7. PubMed ID: 22195920
    [No Abstract]   [Full Text] [Related]  

  • 3. PEGylated starch acetate nanoparticles and its potential use for oral insulin delivery.
    Minimol PF; Paul W; Sharma CP
    Carbohydr Polym; 2013 Jun; 95(1):1-8. PubMed ID: 23618232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of manufacturing parameters on the release profiles of casein-loaded alginate microspheres prepared by emulsification/internal gelation.
    Li R; Zhang X; Shi H
    J Control Release; 2011 Nov; 152 Suppl 1():e154-5. PubMed ID: 22195817
    [No Abstract]   [Full Text] [Related]  

  • 5. An efficient pH sensitive oral insulin delivery system enhanced by deoxycholic acid.
    Zhao L; Ding J; He P; Xiao C; Tang Z; Zhuang X; Chen X
    J Control Release; 2011 Nov; 152 Suppl 1():e184-6. PubMed ID: 22195840
    [No Abstract]   [Full Text] [Related]  

  • 6. Design, development and optimization of a novel time and pH-dependent colon targeted drug delivery system.
    Patel MM; Shah TJ; Amin AF; Shah NN
    Pharm Dev Technol; 2009; 14(1):62-9. PubMed ID: 18802844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of sensor elements to control drug release from capsular drug delivery systems.
    Gröning R; Danco I; Müller RS
    Int J Pharm; 2007 Aug; 340(1-2):61-4. PubMed ID: 17462841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective protection and controlled release of insulin by cationic beta-cyclodextrin polymers from alginate/chitosan nanoparticles.
    Zhang N; Li J; Jiang W; Ren C; Li J; Xin J; Li K
    Int J Pharm; 2010 Jun; 393(1-2):212-8. PubMed ID: 20394813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled release of bovine serum albumin from electrospun fibrous membranes via an improved emulsion-core technique.
    Zhang H; Zhao Y; Han F; Wang M; Yuan X
    J Control Release; 2011 Nov; 152 Suppl 1():e181-2. PubMed ID: 22195838
    [No Abstract]   [Full Text] [Related]  

  • 10. Carboxymethyl starch and lecithin complex as matrix for targeted drug delivery: I. Monolithic mesalamine forms for colon delivery.
    Mihaela Friciu M; Canh Le T; Ispas-Szabo P; Mateescu MA
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):521-30. PubMed ID: 23562535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual drug release from coaxial electrospun nanofibers.
    Su Y; Mo X
    J Control Release; 2011 Nov; 152 Suppl 1():e82-4. PubMed ID: 22195944
    [No Abstract]   [Full Text] [Related]  

  • 13. An oral colon-targeting controlled release system based on resistant starch acetate: synthetization, characterization, and preparation of film-coating pellets.
    Pu H; Chen L; Li X; Xie F; Yu L; Li L
    J Agric Food Chem; 2011 May; 59(10):5738-45. PubMed ID: 21513356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivery of protein drugs using nanoparticles self-assembled from dextran sulfate and quaternized chitosan.
    Shu S; Zhang X; Wu Z; Wang Z; Li C
    J Control Release; 2011 Nov; 152 Suppl 1():e170-2. PubMed ID: 22195830
    [No Abstract]   [Full Text] [Related]  

  • 15. Feasibility, stability and release performance of a time-dependent insulin delivery system intended for oral colon release.
    Maroni A; Del Curto MD; Serratoni M; Zema L; Foppoli A; Gazzaniga A; Sangalli ME
    Eur J Pharm Biopharm; 2009 May; 72(1):246-51. PubMed ID: 19121388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel hyaluronan based biodegradable hydrogel and its drug release behavior.
    Fan C; Zhang C; Liao L; Liu L
    J Control Release; 2011 Nov; 152 Suppl 1():e57-8. PubMed ID: 22195925
    [No Abstract]   [Full Text] [Related]  

  • 17. Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: screening of formulation variables and in vitro investigation.
    Liu H; Yang XG; Nie SF; Wei LL; Zhou LL; Liu H; Tang R; Pan WS
    Int J Pharm; 2007 Mar; 332(1-2):115-24. PubMed ID: 17052871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inclusion of telmisartan in mesocellular foam nanoparticles: drug loading and release property.
    Zhang Y; Jiang T; Zhang Q; Wang S
    Eur J Pharm Biopharm; 2010 Sep; 76(1):17-23. PubMed ID: 20685333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistant starch as a carrier for oral colon-targeting drug matrix system.
    Chen L; Li X; Pang Y; Li L; Zhang X; Yu L
    J Mater Sci Mater Med; 2007 Nov; 18(11):2199-203. PubMed ID: 17665124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.